Shenzhen Vanke Meisha Academy, Zhao Yuchen, 518000, China
This passage is based on the ongoing COVID-19 pandemic. The first part of this passage compares COVID-19 virus with normal influenza virus, summarizes the significant facts about COVID-19, and talks about COVID’s viral proliferation process. The second part mainly explains 3 potential therapeutic drugs against COVID and proposes 2 other treatments. This passage is about 10 pages.
COVID Proliferation, Potential Drugs, Mortality, Trials’ Results
Zhao Yuchen. COVID-19’s replication and potential therapeutic drugs. International Journal of New Developments in Engineering and Society (2020) Vol.4, Issue 4: 142-149. https://doi.org/10.25236/IJNDES.040414.
McIntosh, K. “Coronavirus Disease 2019 (COVID-19).” UpToDate, 20 Apr. 2020, www.uptodate.com/contents/search.
“Q&A: Influenza and COVID-19 - Similarities and Differences.” World Health Organization, World Health Organization, 17 Mar. 2020, www.who.int/emergencies/diseases/novel-coronavirus-2019/question-and-answers-hub/q-a-detail/q-a-similarities-and-differences-covid-19-and-influenza?
“Symptoms of Coronavirus.” Centers for Disease Control and Prevention, Centers for Disease Control and Prevention, 13 May 2020, www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html.
“Coronavirus.” World Health Organization, World Health Organization, 17 Mar. 2020, www.who.int/health-topics/coronavirus#tab=tab_1.
Bergmann, Cornelia C., and Robert H. Silverman. “COVID-19: Coronavirus Replication, Pathogenesis, and Therapeutic Strategies.” Cleveland Clinic Journal of Medicine, Cleveland Clinic Journal of Medicine, 4 May 2020, www.ccjm.org/content/early/2020/05/12/ccjm.87a.20047.
Liubin，Qinzhaolin，Qizhongtian . Genome structure and protein function of coronavirus ", Department of Microbiology and Infection, Naval Military Medical University, 1 Jan, jmi.fudan.edu.cn/CN/abstract/abstract825.shtml.
Zhaolinyu, Chinanews. “Novel coronavirus: simple structure, simple composition, but not simple destructive power, 31 Jan. 2020, www.chinanews.com/sh/2020/01-31/9074432.shtml.
Krishna Sriram, Postdoctoral Fellow, et al. “What Is the ACE2 Receptor, How Is It Connected to Coronavirus and Why Might It Be Key to Treating COVID-19? The Experts Explain.” The Conversation, 23 June 2020, theconversation.com/what-is-the-ace2-receptor-how-is-it-connected-to-coronavirus-and-why-might-it-be-key-to-treating-covid-19-the-experts-explain-136928.
Anderson, Hayley. “Lysosomes - Types, Morphology, Function, Process and Microscopy.” MicroscopeMaster, 13 Oct. 2010, www.microscopemaster.com/lysosomes.html.
Kai Kupferschmidt Jun. 9, 2020, et al. “Three Big Studies Dim Hopes That Hydroxychloroquine Can Treat or Prevent COVID-19.” Science, 9 June 2020, www.sciencemag.org/news/2020/06/three-big-studies-dim-hopes-hydroxychloroquine-can-treat-or-prevent-covid-19.
Hagen, M.S, Ashley. “Antimicrobials and COVID-19: Strategies for Treating a Pandemic.” ASM.org, 23 Mar. 2020, asm.org/Articles/2020/March/Antimicrobials-and-COVID-19-Treatment-Strategies-f.
Tran, Jennifer. “COVID-19 Treatments: An Updated List of Drugs and Medications in Development - GoodRx.” The GoodRx Prescription Savings Blog, 15 July 2020, www.goodrx.com/blog/coronavirus-treatments-on-the-way.
Patel IH, Zhang X, Nieforth K, Salgo M;Buss N; “Pharmacokinetics, Pharmacodynamics and Drug Interaction Potential of Enfuvirtide.” Clinical Pharmacokinetics, U.S. National Library of Medicine, 2005, pubmed.ncbi.nlm.nih.gov/15656696/.
“IHME: COVID-19 Projections.” Institute for Health Metrics and Evaluation, 2020, covid19.healthdata.org/global?view=social-distancing.